Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
128 studies found for:    "DMD-associated dilated cardiomyopathy" OR "Cardiomyopathy, Dilated"
Show Display Options
RSS Create an RSS feed from your search for:
"DMD-associated dilated cardiomyopathy" OR "Cardiomyopathy, Dilated"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Suspended Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Procedure: Intracoronary autologous stem cell infusion
2 Terminated Cell Therapy in Dilated Cardiomyopathy: Observational Study
Condition: Cardiomyopathy, Dilated
Intervention: Other: Cell therapy
3 Recruiting Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Biological: Autologous stem cell therapy
4 Terminated
Has Results
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
Condition: Cardiomyopathy, Dilated
Intervention: Device: Mysorba
5 Recruiting Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Other: CMR using T1 mapping technique
6 Completed Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Metoprolol
7 Recruiting A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: protein A immunoadsorption
8 Completed Nesiritide - Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Nesiritide;   Drug: 5% Dextrose
9 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
10 Unknown  Cell Therapy In Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Stem cell
11 Completed
Has Results
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: CD34+ autologous stem cell transplantation;   Drug: Bone Marrow Stimulation;   Biological: SC therapy
12 Completed
Has Results
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Coenzyme Q10;   Drug: Placebo
13 Terminated Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Rosiglitazone therapy
14 Unknown  Pathophysiology of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
15 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
16 Completed Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Intracoronary infusion of autologous bone marrow cells
17 Terminated PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Condition: Dilated Cardiomyopathy
Interventions: Drug: perindopril;   Drug: placebo
18 Completed Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: granulocyte colony stimulating factor (GCSF);   Procedure: bone marrow mononuclear cells
19 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
20 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.